Updates from The Motley Fool

Latest updates on MannKind Corp from Fool.com.


Stock Performance

MNKD vs. S&P 500 | 2 Year Performance
MNKD 1-Day Stock Chart
MNKD 5-Day Stock Chart
MNKD 1-Month Stock Chart
MNKD 3-Month Stock Chart
MNKD 6-Month Stock Chart
MNKD 1-Year Stock Chart
MNKD 2-Year Stock Chart
MNKD 5-Year Stock Chart
View Interactive MNKD Charts
Sponsored by

Key Data Points

Primary metrics and data points about MannKind Corp.
Current Price: $1.35
Prev Close: $1.44
Open: $1.38
Bid: $1.36
Ask: $1.39
Day's Range: $1.33 - $1.41
52wk Range: $0.64 - $7.32
Volume: 2,914,193
Avg Vol 7,493,166
Market Cap: $552.81M
P/E (ttm): -1.58
EPS (ttm): -$0.91
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about MannKind Corp.
CAPS Rating 1 out of 5
 
706 Outperform
145 Underperform
CAPS All Stars
 
82 Outperform
42 Underperform

How do you think MannKind Corp will perform against the market?



You pick for MannKind Corp is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Hakan S. Edstrom, CEO

33% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for MannKind Corp.

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers